337 related articles for article (PubMed ID: 8733393)
1. Minocycline-induced hyperpigmentation in leprosy.
Fleming CJ; Hunt MJ; Salisbury EL; McCarthy SW; Barnetson RS
Br J Dermatol; 1996 Apr; 134(4):784-7. PubMed ID: 8733393
[TBL] [Abstract][Full Text] [Related]
2. Persistent serpentine supravenous hyperpigmented eruption in lepromatous leprosy after minocycline.
Narang T; Dogra S; Sakia UN
Lepr Rev; 2015 Jun; 86(2):191-4. PubMed ID: 26502692
[TBL] [Abstract][Full Text] [Related]
3. Minocycline-induced hyperpigmentation in multibacillary leprosy.
Hu SW; Robinson MR; Newlove T; Meehan S; Levis WR; Patel RR
Am J Dermatopathol; 2012 Dec; 34(8):e114-8. PubMed ID: 23169418
[TBL] [Abstract][Full Text] [Related]
4. Case reports: minocycline-induced hyperpigmentation resolves during oral isotretinoin therapy.
Soung J; Cohen J; Phelps R; Cohen SR
J Drugs Dermatol; 2007 Dec; 6(12):1232-6. PubMed ID: 18189065
[TBL] [Abstract][Full Text] [Related]
5. Trials of daily, long-term minocycline and rifampin or clarithromycin and rifampin in the treatment of borderline lepromatous and lepromatous leprosy.
Rea TH
Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):129-35. PubMed ID: 11036492
[TBL] [Abstract][Full Text] [Related]
6. Minocycline is effective and cosmetically preferred to clofazimine by leprosy patients in New York.
Levis WR; Spencer TI; Ladizinski B
J Drugs Dermatol; 2010 Aug; 9(8):906. PubMed ID: 20684139
[No Abstract] [Full Text] [Related]
7. Minocycline hyperpigmentation isolated to the subcutaneous fat.
Rahman Z; Lazova R; Antaya RJ
J Cutan Pathol; 2005 Aug; 32(7):516-9. PubMed ID: 16008698
[TBL] [Abstract][Full Text] [Related]
8. Borderline lepromatous leprosy presenting as a single cutaneous plaque.
Armour KS; Scolyer RA; Barnetson RS
Australas J Dermatol; 2005 Aug; 46(3):181-3. PubMed ID: 16008652
[TBL] [Abstract][Full Text] [Related]
9. Minocycline-induced hyperpigmentation treated with a 755-nm Q-switched alexandrite laser.
Alster TS; Gupta SN
Dermatol Surg; 2004 Sep; 30(9):1201-4. PubMed ID: 15355359
[TBL] [Abstract][Full Text] [Related]
10. Minocycline-induced hyperpigmentation.
Hung PH; Caldwell JB; James WD
J Fam Pract; 1995 Aug; 41(2):183-5. PubMed ID: 7636458
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of minocycline in single dose and at 100 mg twice daily for lepromatous leprosy.
Gelber RH; Murray LP; Siu P; Tsang M; Rea TH
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):568-73. PubMed ID: 7868955
[TBL] [Abstract][Full Text] [Related]
12. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
Mane I; Cartel JL; Grosset JH
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
[TBL] [Abstract][Full Text] [Related]
13. Minocycline-induced skin pigmentation: an update.
Geria AN; Tajirian AL; Kihiczak G; Schwartz RA
Acta Dermatovenerol Croat; 2009; 17(2):123-6. PubMed ID: 19595269
[TBL] [Abstract][Full Text] [Related]
14. Treatment of minocycline-induced hyperpigmentation with the Q-switched ruby laser.
Tsao H; Busam K; Barnhill RL; Dover JS
Arch Dermatol; 1996 Oct; 132(10):1250-1. PubMed ID: 8859045
[No Abstract] [Full Text] [Related]
15. Minocycline-induced pigmentation of pre-existing capillaritis.
Madan V; Lear JT
Br J Dermatol; 2007 Mar; 156(3):590-1. PubMed ID: 17300262
[No Abstract] [Full Text] [Related]
16. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
[TBL] [Abstract][Full Text] [Related]
17. Dermacase. Minocycline-induced pigmentation.
Kalia S; Adams SP
Can Fam Physician; 2006 May; 52(5):595-6. PubMed ID: 16739831
[No Abstract] [Full Text] [Related]
18. Lepromatous leprosy: nasal manifestations and treatment with minocycline.
Lalwani AK; Tami TA; Gelber RH
Ann Otol Rhinol Laryngol; 1992 Mar; 101(3):261-4. PubMed ID: 1543336
[TBL] [Abstract][Full Text] [Related]
19. Revisiting safety of minocycline as neuroprotection in Huntington's disease.
Reynolds N
Mov Disord; 2007 Jan; 22(2):292. PubMed ID: 17083098
[No Abstract] [Full Text] [Related]
20. Minocycline-induced pigmentation of the aortic valve and sinuses of Valsalva.
Belcher E; Soni M; Azeem F; Sheppard MN; Petrou M
Ann Thorac Surg; 2009 Nov; 88(5):1704. PubMed ID: 19853151
[No Abstract] [Full Text] [Related]
[Next] [New Search]
